Contamination of synthetic HuD protein spanning peptide pools with a CMV-encoded peptide

Cytometry Part A

Volumn 73, Issue 11, 2008, Pages 1079-1085

  De Graaf, Marieke T ^a   De Beukelaar, Janet W ^a   Burgers, Peter C ^a   Luider, Theo M ^a   Kraan, Jaco ^a   Sillevis Smitt, Peter A ^a   Gratama, Jan W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

CMV encoded peptide; HLA restriction; Hu antibodies; Mass spectrometry; Paraneoplastic neurological syndromes; Protein spanning peptide pools; T lymphocytes

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HU ANTIGEN; IMMEDIATE EARLY PROTEIN; PEPTIDE; PROTEIN SPANNING PEPTIDE POOL HUD; UNCLASSIFIED DRUG;

ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOMEGALOVIRUS; FALSE POSITIVE RESULT; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOSTIMULATION; ION CYCLOTRON RESONANCE MASS SPECTROMETRY; MAJOR CLINICAL STUDY; PARANEOPLASTIC NEUROPATHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SYNTHESIS; REPRODUCIBILITY; T LYMPHOCYTE ACTIVATION; TANDEM MASS SPECTROMETRY; VIRAL CONTAMINATION;

AMINO ACID SEQUENCE; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; HISTOCOMPATIBILITY TESTING; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; PEPTIDES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 55949119029     PISSN: 15524922     EISSN: 15524930     Source Type: Journal    
DOI: 10.1002/cyto.a.20636     Document Type: Article

References (20)

1. Kern F, Faulhaber N, Frommel C, Khatamzas E, Prosch S, Schonemann C, Kretzschmar I, Volkmer-Engert R, Volk HD, Reinke P. Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides. Eur J Immunol 2000;30:1676-1682.
2. Maecker HT, Dunn HS, Suni MA, Khatamzas E, Pitcher CJ, Bunde T, Persaud N, Trigona W, Fu TM, Sinclair E, Bredt BM, McCune JM, Maino VC, Kern F, Picker LJ. Use of overlapping peptide mixtures as antigens for cytokine flow cytometry. J Immunol Methods 2001;255(1-2):27-40.
3. de Beukelaar JW, Gratama JW, Smitt PA, Verjans GM, Kraan J, Luider TM, Burgers PC. The impact of impurities in synthetic peptides on the outcome of T-cell stimulation assays. Rapid Commun Mass Spectrom 2007;21:1282-1288.
4. de Beukelaar JW, Verjans GM, van Norden Y, Milikan JC, Kraan J, Hooijkaas H, Sintnicolaas K, Gratama JW, Sillevis Smitt PA. No evidence for circulating HuD-specific CD8+ T cells in patients with paraneoplastic neurological syndromes and Hu antibodies. Cancer Immunol Immunother 2007;56:1501-1506.
5. Kern F, Surel IP, Brock C, Freistedt B, Radtke H, Scheffold A, Blasczyk R, Reinke P, Schneider-Mergener J, Radbruch A, Walden P, Volk HD. T-cell epitope mapping by flow cytometry. Nat Med 1998;4:975-978.
6. Sanz-Nebot V, Benavente F, Toro I, Barbosa J. Liquid chromatography-mass spectrometry approach for the characterization and purification of crude synthetic peptide hormones. Anal Bioanal Chem 2003;377:306-315.
7. Baykut G, Jertz R, Witt M. Matrix-assisted laser desorption/ionization Fourier transform ion cyclotron resonance mass spectrometry with pulsed in-source collision gas and in-source ion accumulation. Rapid Commun Mass Spectrom 2000;14:1238-1247.
8. O'Connor PB, Costello CE. Application of multishot acquisition in Fourier transform mass spectrometry. Anal Chem 2000;72:5125-5130.
9. Mize TH, Amster IJ. Broad-band ion accumulation with an internal source MALDIFTICR-MS. Anal Chem 2000;72:5886-5891.
10. Moyer SC, Budnik BA, Pittman JL, Costello CE, O'Connor PB. Attomole peptide analysis by high-pressure matrix-assisted laser desorption/ionization Fourier transform mass spectrometry. Anal Chem 2003;75:6449-6454.
11. Gratama JW, Kern F. Flow cytometric enumeration of antigen-specific T lymphocytes. Cytometry A 2004;58A:79-86.
12. Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S SYFPEITHI: Database for MHC ligands and peptide motifs. Immunogenetics 1999;50:213-219.
13. Rammensee HG, Friede T, Stevanoviic S. MHC ligands and peptide motifs: First listing. Immunogenetics 1995;41:178-228.
14. Parker KC, Bednarek MA, Coligan JE. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 1994;152:163-175.
15. Buus S, Lauemoller SL, Worning P, Kesmir C, Frimurer T, Corbet S, Fomsgaard A, Hilden J, Holm A, Brunak S. Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach. Tissue Antigens 2003;62:378-384.
16. Nielsen M, Lundegaard C, Worning P, Lauemoller SL, Lamberth K, Buus S, Brunak S, Lund O. Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci 2003;12:1007-1017.
17. Vita R, Peters B, Sette A. The Curation Guidelines of the Immune Epitope Database and Analysis Resource. Cytometry 2008;73A: in press. DOI: 10.1002/cyto.a.20585 (this issue).
18. Gavin MA, Gilbert MJ, Riddell SR, Greenberg PD, Bevan MJ. Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes. J Immunol 1993;151:3971-3980.
19. Currier JR, Galley LM, Wenschuh H, Morafo V, Ratto-Kim S, Gray CM, Maboko L, Hoelscher M, Marovich MA, Cox JH. Peptide impurities in commercial synthetic peptides and their implications for vaccine trial assessment. Clin Vaccine Immunol 2008;15:267-276.
20. De Spiegeleer B, Vergote V, Pezeshki A, Peremans K, Burvenich C. Impurity profiling quality control testing of synthetic peptides using liquid chromatography-photodiode array-fluorescence and liquid chromatography- electrospray ionization-mass spectrometry: The obestatin case. Anal Biochem 2008;376:229-234.